- Home
- MIST vs ELME Comparison
MIST vs ELME Comparison
Compare MIST & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ELME |
|---|---|---|
| Founded | 2003 | 1960 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 198.2M |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MIST | ELME |
|---|---|---|
| Price | $1.52 | $2.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | $8.50 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 741.95% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $206,360,000.00 |
| Revenue This Year | $2,915.14 | $5.03 |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.98 |
| 52 Week High | $3.06 | $17.68 |
Technical Indicators
Market Signals| Indicator | MIST | ELME |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 23.19 |
| Support Level | $1.38 | $1.98 |
| Resistance Level | $2.01 | $2.26 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 65.19 | 29.63 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.